These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 2125221)

  • 1. Characteristics of two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P450.
    Zbaida S; Levine WG
    Biochem Pharmacol; 1990 Dec; 40(11):2415-23. PubMed ID: 2125221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN.
    Levine WG; Raza H
    Drug Metab Dispos; 1988; 16(3):441-8. PubMed ID: 2900738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple mechanisms in hepatic microsomal azoreduction.
    Levine WG; Stoddart A; Zbaida S
    Xenobiotica; 1992; 22(9-10):1111-20. PubMed ID: 1441602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel application of cyclic voltammetry for direct investigation of metabolic intermediates in microsomal azo reduction.
    Zbaida S; Levine WG
    Chem Res Toxicol; 1991; 4(1):82-8. PubMed ID: 1912304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of microsomal azoreduction: predictions based on electronic aspects of structure-activity relationships.
    Zbaida S
    Drug Metab Rev; 1995; 27(3):497-516. PubMed ID: 8521752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic microsomal azoreductase activity. Reactivity of azo dye substrates is determined by their electron densities and redox potentials.
    Zbaida S; Brewer CF; Levine WG
    Drug Metab Dispos; 1994; 22(3):412-8. PubMed ID: 8070318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrates for microsomal azoreductase. Hammett substituent effects, NMR studies, and response to inhibitors.
    Zbaida S; Brewer CF; Levine WG
    Drug Metab Dispos; 1992; 20(6):902-8. PubMed ID: 1362944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
    Goeptar AR; te Koppele JM; van Maanen JM; Zoetemelk CE; Vermeulen NP
    Biochem Pharmacol; 1992 Jan; 43(2):343-52. PubMed ID: 1310854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azoreduction of N,N-dimethyl-4-aminoazobenzene (DAB) by rat hepatic microsomes. Selective induction by clofibrate.
    Raza H; Levine WG
    Drug Metab Dispos; 1986; 14(1):19-24. PubMed ID: 2868860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of electronic factors in binding and reduction of azo dyes by hepatic microsomes.
    Zbaida S; Levine WG
    J Pharmacol Exp Ther; 1992 Feb; 260(2):554-61. PubMed ID: 1738106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450.
    Dutton DR; Parkinson A
    Arch Biochem Biophys; 1989 Feb; 268(2):617-29. PubMed ID: 2536534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of thiol environment of the N-demethylation and ring hydroxylation of N,N-dimethyl-4-aminoazobenzene (DAB) by rat liver microsomes.
    Levine WG
    Drug Metab Dispos; 1986; 14(1):13-8. PubMed ID: 2868856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a predominantly NADH-dependent O-dealkylating system in rat hepatic microsomes.
    Kuwahara S; Mannering GJ
    Biochem Pharmacol; 1985 Dec; 34(24):4215-28. PubMed ID: 3935115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two sites of azo reduction in the monooxygenase system.
    Peterson FJ; Holtzman JL; Crankshaw D; Mason RP
    Mol Pharmacol; 1988 Oct; 34(4):597-603. PubMed ID: 2845254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase.
    Vromans RM; van de Straat R; Groeneveld M; Vermeulen NP
    Xenobiotica; 1990 Sep; 20(9):967-78. PubMed ID: 2122607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes.
    Mikalsen A; Alexander J; Wallin H; Ingelman-Sundberg M; Andersen RA
    Carcinogenesis; 1991 May; 12(5):825-31. PubMed ID: 1903091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the continuous administration of N,N-dimethyl-4-phenylazoaniline (DAB) on the activities and the inducibilities of some drug-metabolizing enzymes in rat liver.
    Autrup H; Thurlow BJ; Warwick GP
    Chem Biol Interact; 1975 Nov; 11(5):313-28. PubMed ID: 148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox cycling of resorufin catalyzed by rat liver microsomal NADPH-cytochrome P450 reductase.
    Dutton DR; Reed GA; Parkinson A
    Arch Biochem Biophys; 1989 Feb; 268(2):605-16. PubMed ID: 2464338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of monomeric reconstituted and membrane microsomal monooxygenase systems of the rabbit liver. II. Kinetic parameters of reductase and monooxygenase reactions.
    Kanaeva IP; Nikityuk OV; Davydov DR; Dedinskii IR; Koen YM; Kuznetsova GP; Skotselyas ED; Bachmanova GI; Archakov AI
    Arch Biochem Biophys; 1992 Nov; 298(2):403-12. PubMed ID: 1416971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of a cytochrome P450 system in microsomal debromination of alpha-(bromisovaleryl)urea.
    Oka K; Kitamura S; Tatsumi K
    J Pharm Pharmacol; 1996 Sep; 48(9):930-2. PubMed ID: 8910855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.